Ultragenyx Pharmaceutical Inc. (RARE) Posts Q1 Loss of 85c/Share

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) reported Q1 EPS of ($0.85), $0.48 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Ultragenyx Pharmaceutical Inc. (RARE) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Bit Digital (BTBT) Misses Q2 EPS by 27c
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating